IBOPRES

Ibogaine Dr.Moshe Zer -Zion Beer-Yaacov Mental Health Center Israel

Ibogaine ,[object Object],[object Object],[object Object],[object Object]

Forms in Current Use ,[object Object]

Forms in Current Use ,[object Object],[object Object]

Brief Historical Time Line ,[object Object],[object Object],[object Object],[object Object]

Brief Historical Time Line ,[object Object],[object Object],[object Object]

Brief Historical Time Line ,[object Object]

Mechanisms of Action ,[object Object],[object Object],[object Object]

Glutamate ,[object Object],[object Object]

Glutamate ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Glutamate ,[object Object],[object Object],[object Object],[object Object]

Opioid ,[object Object],[object Object],[object Object],[object Object]

Serotonin ,[object Object],[object Object],[object Object]

Dopamine ,[object Object],[object Object],[object Object]

Acetylcholine ,[object Object],[object Object],[object Object]

Sigma Receptors ,[object Object],[object Object],[object Object],[object Object]

Sigma Receptors ,[object Object],[object Object],[object Object]

Glial cell line-derived neurotrophic factor (GDNF) ,[object Object],[object Object],[object Object]

Summary of Mechanisms of Action of Ibogaine ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Possible effects on Neuroadaptations Related to Drug Sensitization or Tolerance ,[object Object],[object Object],[object Object]

Evidence of efficacy in Animal models ,[object Object],[object Object],[object Object],[object Object],[object Object]

Drug Self-Administration ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Acute Opioid withdrawal ,[object Object],[object Object]

Conditioned place preference ,[object Object]

Locomotor activity ,[object Object]

Dopamine efflux . ,[object Object],[object Object],[object Object]

Evidence of efficacy and subjective effects in humans ,[object Object],[object Object],[object Object],[object Object]

Acute Opioid withdrawal ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Long-TermOutcomes ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Subjective Effects ,[object Object],[object Object],[object Object],[object Object]

Subjective Effects ,[object Object],[object Object],[object Object],[object Object],[object Object]

Subjective Effects ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Pharmacokinetics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Pharmacokinetics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Each form has ,[object Object],[object Object],[object Object]

Dose and Dose Regimen ,[object Object],[object Object],[object Object],[object Object],[object Object]

Dose and Dose Regimen ,[object Object],[object Object],[object Object]

Dose and Dose Regimen ,[object Object],[object Object]

Frequent side effects of Ibogaine ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Safety ,[object Object],[object Object],[object Object],[object Object],[object Object]

Safety ,[object Object],[object Object],[object Object]

Observations in Humans ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Observations in Humans ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Observations in Humans ,[object Object],[object Object],[object Object],[object Object],[object Object]

Abuse liability ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

IBOPRES

Empfohlen

Empfohlen

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Andere mochten auch

Andere mochten auch (6)

Ähnlich wie IBOPRES

Ähnlich wie IBOPRES (20)

Mehr von Sheldon Pelletier

Mehr von Sheldon Pelletier (17)

Kürzlich hochgeladen

Kürzlich hochgeladen (20)

IBOPRES